Loading viewer...
investor_presentation
Format: PDF investor_presentation
Medicalgorithmics investor presentation covering Q1 2024 financial results, strategy execution, and the functional integration of MDG with Kardiolytics. The presentation outlines growth strategy and outlook for 2024 following BioFund investment.
investor_presentation
109 Pages
Instructure
Teva Pharmaceutical Industries Investor Presentation — July 2021
investor_presentationinvestor_presentation
38 Pages
Teva Pharmaceutical Industries
Verizon Communications Investor Presentation — May 2018
investor_presentationinvestor_presentation
34 Pages
Verizon Communications Inc.